MDMA
Properties
- Molecular formula
- C11H15NO2
- Molar mass
- 193.25 g/mol
- Exact mass
- 193.1103 Da
- Boiling point
- 100–110 °C (at 0.4 Torr)
- pKa
- 9.9
- logP
- 1.57Crippen estimate
- Polar surface area
- 30.5 Ų
- H-bond donors / acceptors
- 1 / 3
- Rotatable bonds
- 3
Midomafetamine (MDMA) - submitted to the FDA in 2024 as the first psychedelic to reach a PDUFA decision in modern history. The agency issued a Complete Response Letter on 9 August 2024 requesting an additional Phase-3 trial despite Phase-3 data showing 67% of MDMA-arm participants no longer meeting PTSD diagnostic criteria (vs 32% on placebo). Sponsor Lykos Therapeutics restructured by ~75% and the FDA released the full CRL in September 2025. When the Trump administration's 18 April 2026 psychedelic executive order paired with FDA priority vouchers, MDMA was conspicuously not among the three picks - vouchers went instead to two psilocybin programs and Transcend Therapeutics' methylone, leaving MDMA-AT in regulatory limbo while the rest of the field accelerates.
Hazards
Not classified as hazardous under GHS. Aggregated from the ECHA notifications, via PubChem; a share says how many notifiers assign that statement.
Identifiers
42542-10-9CNC(C)Cc1ccc2c(c1)OCO2SHXWCVYOXRDMCX-UHFFFAOYSA-NInChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3Weigh it out
Type any one amount. The others follow from the molar mass.
Names and synonyms
20 names · show all
- 3,4-Methylenedioxymethamphetamine
- 1,3-Benzodioxole-5-ethanamine, N,α-dimethyl-
- (±)-N-Methyl-3,4-(methylenedioxy)amphetamine
- (±)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane
- (±)-(3,4-Methylenedioxy)methamphetamine
- Ecstasy
- Dl-(3,4-Methylenedioxy)methamphetamine
- (RS)-3,4-(Methylenedioxy)methamphetamine
- XTC
- 3,4-Methylenedioxy-N-methylamphetamine
- Methylenedioxymethamphetamine
- N-Methyl-3,4-methylenedioxyamphetamine
- rac-1-(1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine
- Midomafetamine
- [1-(2H-1,3-Benzodioxol-5-yl)propan-2-yl](methyl)amine
- 1-Benzo[1,3]dioxol-5-yl-N-methyl-propan-2-amine
- (±)-MDMA hydrochloride
- Phenethylamine, N,α-dimethyl-3,4-methylenedioxy-
- N,α-Dimethyl-1,3-benzodioxole-5-ethanamine
- 3,4-Methylenedioxy-N,α-dimethyl-β-phenylethylamine
Work with MDMA
Similar compounds
Tanimoto similarity of circular fingerprints over the whole catalogue. All similar compounds